PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical Endocrinology10.1111/cen.145802021963413-418Is thyroid hormone supplementation avoidable for patients with low‐risk papillary thyroid cancer after thyroid lobectomy? A two‐center observational studyLiu Xiao, Jie Wu, Lisha Jiang, Yangmengyuan Xu, Bin Liuhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14580, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cen.14580, https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14580
VideoEndocrinology10.1089/ve.2022.00052022917-8Optimal Serum Thyroid-Stimulating Hormone Level for Patients with Papillary Thyroid Carcinoma After LobectomyJie Liuhttps://www.liebertpub.com/doi/full-xml/10.1089/ve.2022.0005, https://www.liebertpub.com/doi/pdf/10.1089/ve.2022.0005
Endocrinology and Metabolism10.3803/enm.2019.34.2.1502019342150Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid CancerMyung-Chul Lee, Min Joo Kim, Hoon Sung Choi, Sun Wook Cho, Guk Haeng Lee, Young Joo Park, Do Joon Parkhttps://synapse.koreamed.org/pdf/10.3803/EnM.2019.34.2.150, https://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2019.34.2.150, https://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2019.34.2.150
Thyroid10.1089/thy.2012.0183201222101007-1015Recombinant Human Thyroid Stimulating Hormone–Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of RecurrenceJonathan Hugo, Eyal Robenshtok, Ravinder Grewal, Steve Larson, R. Michael Tuttlehttps://www.liebertpub.com/doi/full-xml/10.1089/thy.2012.0183, https://www.liebertpub.com/doi/pdf/10.1089/thy.2012.0183
10.21203/rs.3.rs-818671/v12021Thyroid Stimulating Hormone Suppression and Recurrence After Thyroid Lobectomy For Papillary Thyroid CarcinomaMi Rye Bae, Sung Hoon Nam, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kimhttps://www.researchsquare.com/article/rs-818671/v1, https://www.researchsquare.com/article/rs-818671/v1.html
Journal of Surgical Oncology10.1002/jso.251642018The prognostic value of serum thyroid-stimulating hormone level post-lobectomy in low- and intermediate-risk papillary thyroid carcinomaJae Hyun Park, Yu-mi Lee, Yi Ho Lee, Suck Joon Hong, Jong Ho Yoonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjso.25164, http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.25164/fullpdf
Clinical Thyroidology10.1089/ct.2021;33.281-2842021336281-284Initiation of Thyroid Hormone Replacement Is Common Following Thyroid Lobectomy for Low-Risk Differentiated Thyroid CancerMaria Papaleontiouhttps://www.liebertpub.com/doi/full-xml/10.1089/ct.2021%3B33.281-284, https://www.liebertpub.com/doi/pdf/10.1089/ct.2021%3B33.281-284
European Thyroid Journal10.1159/00050404720199140-48Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1)Salman Razvi, Vicky Ryan, Lorna Ingoe, Simon H. Pearce, Scott Wilkeshttps://www.karger.com/Article/Pdf/504047, https://www.karger.com/Article/Pdf/504047
Frontiers in Endocrinology10.3389/fendo.2020.619841202111The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up StudyYi Dou, Yingji Chen, Daixing Hu, Xinliang Suhttps://www.frontiersin.org/articles/10.3389/fendo.2020.619841/full
Thyroid10.1089/thy.2021.0100202131111662-1672Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 PatientsLin Yan, Mingbo Zhang, Qing Song, Yukun Luohttps://www.liebertpub.com/doi/full-xml/10.1089/thy.2021.0100, https://www.liebertpub.com/doi/pdf/10.1089/thy.2021.0100